Chugai Pharma Manufacturing Co, Ltd (manufacturing of unpackaged products, primary packaging, quality control testing; quality control testing)

Ukraine

All drugs from this manufacturer

  • HEMLIBRA

    The drug is intended for routine prophylaxis to prevent or reduce the frequency of bleeding in adults and children (from birth) with hemophilia A.

    Dosage form: solution for injection

    Active substance Dosage
    emactuzumab 150 mg/ml

    ATC: B02BX06

  • HEMLIBRA®

    The drug is intended for the prevention and reduction of the frequency of bleeding in adults and children (from birth) with hemophilia A (congenital deficiency of coagulation factor VIII).

    Dosage form: solution for injection

    Active substance Dosage
    active substance 30 mg/ml or 30 mg/ml

    ATC: B02BX06